Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $508.34, signifying a -1.55% m

Nykredit A S purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) i

Baird Financial Group Inc. decreased its holdings in shares of Vertex Pharmaceuticals Incorporated (

Engineers Gate Manager LP lowered its position in shares of Vertex Pharmaceuticals Incorporated (NAS

PPH offers higher income and lower volatility, while BBH delivers stronger growth but with deeper dr

Vertex Pharmaceuticals Incorporated (VRTX) Presents at Morgan Stanley 24th Annual Global Healthcare

Amgen maintains a massive, diversified portfolio of medicines serving approximately 17 million patie

Since 2008, Vertex Pharmaceuticals, Inc. (VRTX) shares have received 42 outlier institutional inflow

Vertex Pharmaceuticals Incorporated (VRTX) Presents at 12th Annual Cantor Fitzgerald Global Healthca

Vertex Pharmaceuticals Incorporated (VRTX) Presents at Wells Fargo 21st Annual Healthcare Conference

In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $528.9, indicating a -3.

Vertex Pharmaceuticals' core business is rock-solid, but it is also slowly expanding into new areas.

Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wi

Representative David J. Taylor, a Republican from Ohio, has reported six congressional stock trades,

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 5.61% on

Tech giant Nvidia has remained ahead of rivals thanks to its competitive advantage. These healthcare

Vertex (VRTX) reported earnings 30 days ago. What's next for the stock?

Morgan Stanley analyst Terence Flynn reinstates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overw

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the succ

Ancora Advisors LLC purchased a new position in shares of Vertex Pharmaceuticals Incorporated (NASDA

Beacon Pointe Advisors LLC purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRT

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 5.32% on

Nvidia revenue more than doubles, Okta and Veeva climb on beats, and more

CNBC's Halftime Report Final Trades: Sechan picked ServiceNow (NYSE: NOW), Lebenthal chose Verte

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 5.35% on

Truist Securities analyst Danielle Brill maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Bu

Barclays analyst Eliana Merle maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight an

TD Cowen analyst Phil Nadeau maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises

Cantor Fitzgerald analyst Carter Gould maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Over

Vertex Pharmaceuticals (NASDAQ:VRTX) raises FY2026 sales outlook from $12.950 billion-$13.100 billio

Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $4.73 per share which met the an

U.S. stock futures up, focus on earnings from Tyson Foods, Marriott, Universal Logistics, Williams C

CNN Money Fear & Greed index improved while remaining in 'Fear' zone on Friday. Amazon u

Seven small-cap stocks have surged as much as 123% in early July on buyouts, FDA developments, refin

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 5 years by 7.55% on a

UBS analyst Michael Yee maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the

Truist Securities analyst Danielle Brill maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Bu

The Halftime Report Final Trades featured stock picks from Bryn Talkington, Jim Lebenthal, Liz Young

RBC Capital analyst Brian Abrahams maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Outperfo

Vertex to acquire Crinetics for $10 billion, adding approved acromegaly drug Palsonify and late-stag

Baird analyst Brian Skorney maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Underperform an

Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) rose in pre-market trading after being acquired by Vert

Crinetics Pharmaceuticals shares are trading higher in Monday's after-hours session after the co

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX),

Vertex Pharmaceuticals today announced that it has signed a Letter of Intent (LOI) with the pan-Cana

FDA expands Vertex Casgevy label to patients aged 2 and older, making about 5,500 more U.S. children

- First and only approved genetic therapy to treat children as young as 2 years for both severe sick

https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-young-children-s

Jim Lebenthal recommends Vertex Pharmaceuticals in the healthcare sector. Jenny Van Leeuwen picks Ve

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 5 years by 8.53% on a